A
Amylyx Pharmaceuticals (AMLX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Amylyx Pharmaceuticals (AMLX)
Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapies for treatment paradigm for amyotrophic lateral sclerosis (ALS), and range of neurodegenerative diseases by keeping neurons alive. The Comp... Read more
- USD3.98
- USD4.18
- USD3.96
- USD19.95
- -22.60%
- 196M
- 550.92k
- 783.42k
- 282M
- 1.58
- -70.70%
Stock News
4 hours ago
Cocoa’s the best-performing commodity in 2024 — and even beat bitcoin. What’s next.
MarketWatch
4 hours ago
BNP Paribas Signs €5.1 Billion Deal to Buy Axa’s Asset Manager
Yahoo
5 hours ago
The Returns At Cigna Group (NYSE:CI) Aren't Growing
Yahoo
7 hours ago
Billionaire Paul Tudor Jones' Fund Just Sold Boeing and Bought This Popular Cryptocurrency Instead
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
